Dr Ravi Amaravadi, a scientific advisor of Sprint Bioscience, was visiting Stockholm last week and held a seminar on the status of his research on autophagy inhibition in cancer patients. The Sprint Bioscience autophagy inhibition team also enjoyed an in-depth discussion with Dr Amaravadi on how VPS34 inhibitors could be best used in cancer treatment.
Following the announcement of the Nobel prize in medicine to Dr Yoshinori Ohsumi, there was a short interview with Dr Amaravadi on Japanese TV the other day regarding autophagy. Watch the interview here.
